Emily Whelan
Key details
- Job title: Partner
- Organisation:WilmerHale
Emily Whelan is a partner at WilmerHale, where she focuses on IP matters in the life sciences, including biotechnology, pharmaceuticals, and chemistry. Her practice includes patent litigation, patent office proceedings, patent prosecution, and strategic IP counseling.
She advises clients across the full lifecycle of IP, from pre-litigation analysis and litigation strategy to post-grant proceedings such as inter partes review and reexamination. Whelan also provides guidance on patent portfolio development and management, competitive landscape assessments, and IP due diligence in connection with corporate transactions.
Her litigation experience includes representing innovator pharmaceutical and biotechnology companies in ANDA and biosimilar disputes, as well as other high-stakes patent matters. In addition, she has handled post-grant challenges in diverse technology areas, including pharmaceuticals and semiconductors, and has worked on prosecution and reexamination of patents in chemical technologies, including emerging areas such as battery materials.
